Terms: = Lymphoma AND MUC16, CA125, CA-125 AND Staging
12 results:
1. Primary lymphoma of the female genital tract masquerading as gynecological malignancy.
Shi S; Li W; Ni G; Ding J; Liu Y; Wu H; Zhang Z; Ding Z
BMC Womens Health; 2024 Apr; 24(1):247. PubMed ID: 38637800
[TBL] [Abstract] [Full Text] [Related]
2. Successful pregnancy via in vitro fertilization in a primary infertile woman with primary lymphoma of the fallopian tube after surgery: A case report and literature review.
Zhang J; Hou Z; Huang J; Xu W; Wang C; Ma X; Lu N; Liu J; Mao Y; Qian Y
Medicine (Baltimore); 2022 Jul; 101(30):e29353. PubMed ID: 35905233
[TBL] [Abstract] [Full Text] [Related]
3. Case of primary bilateral diffuse large B-cell lymphoma of the ovary with plasmablastic features in an HIV-negative female patient.
Guvvala SL; Sakam S; Niazi M; Skaradinskiy Y
BMJ Case Rep; 2017 Feb; 2017():. PubMed ID: 28228433
[TBL] [Abstract] [Full Text] [Related]
4. Role of preoperative sonography in the diagnosis and pathologic staging of pseudomyxoma peritonei.
Li Y; Guo A; Tang J; Wang L; Wang J; Yu D
J Ultrasound Med; 2013 Sep; 32(9):1565-70. PubMed ID: 23980216
[TBL] [Abstract] [Full Text] [Related]
5. PET imaging in the management of tumors of testis and ovary: current thinking and future directions.
Basu S; Rubello D
Minerva Endocrinol; 2008 Sep; 33(3):229-56. PubMed ID: 18846028
[TBL] [Abstract] [Full Text] [Related]
6. [Clinical characteristics and prognostic factors in 73 patients with peripheral T cell lymphoma].
Huang XC; Li XL; Huang RX; Jin XS
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Feb; 33(2):151-5. PubMed ID: 18326910
[TBL] [Abstract] [Full Text] [Related]
7. Serum ca125: a tumor marker for monitoring response to treatment and follow-up in patients with non-Hodgkin's lymphoma.
Zidan J; Hussein O; Basher W; Zohar S
Oncologist; 2004; 9(4):417-21. PubMed ID: 15266095
[TBL] [Abstract] [Full Text] [Related]
8. Serum CA 125 as a prognostic factor in non-Hodgkin's lymphoma.
Bairey O; Blickstein D; Stark P; Prokocimer M; Nativ HM; Kirgner I; Shaklai M
Leuk Lymphoma; 2003 Oct; 44(10):1733-8. PubMed ID: 14692526
[TBL] [Abstract] [Full Text] [Related]
9. The prognostic significance of CA 125 in patients with non-Hodgkin's lymphoma.
Zacharos ID; Efstathiou SP; Petreli E; Georgiou G; Tsioulos DI; Mastorantonakis SE; Christakopoulou I; Roussou PP
Eur J Haematol; 2002 Oct; 69(4):221-6. PubMed ID: 12431241
[TBL] [Abstract] [Full Text] [Related]
10. A new serologic index for low-grade non-Hodgkin's lymphoma based on initial ca125 and LDH serum levels.
Benboubker L; Valat C; Linassier C; Cartron G; Delain M; Bout M; Fetissof F; Lefranq T; Lamagnere JP; Colombat P
Ann Oncol; 2000 Nov; 11(11):1485-91. PubMed ID: 11142490
[TBL] [Abstract] [Full Text] [Related]
11. The biological markers of non-Hodgkin's lymphomas: their role in diagnosis, prognostic assessment and therapeutic strategy.
Morra E
Int J Biol Markers; 1999; 14(3):149-53. PubMed ID: 10569136
[TBL] [Abstract] [Full Text] [Related]
12. Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity.
Lazzarino M; Orlandi E; Klersy C; Astori C; Brusamolino E; Corso A; Bellio L; Gargantini L; Morra E; Bernasconi C
Cancer; 1998 Feb; 82(3):576-82. PubMed ID: 9452277
[TBL] [Abstract] [Full Text] [Related]
